NEW YORK, August 10, 2016 /PRNewswire/ --
The Healthcare sector rose 0.6%, outperforming the other sectors on Tuesday, August 09, 2016. Stock-Callers.com looks at how the following four equities fared at the close: Humana Inc. (NYSE: HUM), Cigna Corp. (NYSE: CI), Molina Healthcare Inc. (NYSE: MOH), and DaVita HealthCare Partners Inc. (NYSE: DVA). You can access of our complimentary research reports on these stocks now at: http://stock-callers.com/registration
At the close on Tuesday, shares in Louisville, Kentucky headquartered Humana Inc. saw a slight decline of 0.29%, ending the day at $177.13. The stock recorded a trading volume of 526,615 shares. The Company's shares have advanced 15.02% in the last one month and 2.24% in the previous three months. The stock is trading above its 50-day and 200-day moving averages by 0.72% and 2.01% respectively. Moreover, shares of Humana, which together with its subsidiaries, operates as a health and well-being company, have a Relative Strength Index (RSI) of 55.83.
On July 22nd, 2016, research firm RBC Capital Markets reiterated its 'Outperform' rating on the Company's stock with an increase of the target price from $220 a share to $224 a share.
On August 3rd, 2016, Humana reported GAAP pretax income of $636 million for 2Q 2016 compared to $793 million in 2Q 2015. The company's adjusted pretax income for 2Q 2016 was $682 million versus $550 million in 2Q 2015. Humana's diluted earnings per share on adjusted basis came in at $2.30 for 2Q 2016 as compared to diluted earnings per share on adjusted basis of $1.77 in 2Q 2015. Visit us today and download your complete report on HUM for free at: http://stock-callers.com/registration/?symbol=HUM
Shares in Bloomfield, Connecticut headquartered Cigna Corp. ended the day 0.95% lower at $127.17 and with a total volume of 1.40 million shares traded. The stock is trading below its 50-day moving average by 2.04%. Shares of the Company, which provides insurance and related products and services in the US and internationally, have an RSI of 44.18.
On July 29th, 2016, Cigna reported that total revenues were $10.0 billion for Q2 2016, an increase of 5% over Q2 2015, driven by continued growth in Cigna's targeted customer segments. For Q2 2016, shareholders' net income was $510 million, or $1.97 per share, compared to $588 million, or $2.26 per share, for Q2 2015. The complimentary research report on CI can be accessed at: http://stock-callers.com/registration/?symbol=CI Molina Healthcare
On Tuesday, shares in Long Beach, California headquartered Molina Healthcare Inc. finished 0.17% lower at $58.19 and with a total volume of 621,515 shares traded. The stock has advanced 14.32% in the last one month and 23.91% over the previous three months. The Company's shares are trading above their 50-day and 200-day moving averages by 12.10% and 1.65%, respectively. Additionally, shares of Molina Healthcare, which provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program, have an RSI of 66.87.
On August 2nd, 2016, Molina Healthcare announced that it will acquire, in all-cash transactions, certain assets related to Aetna and Humana's Medicare Advantage businesses in 21 states which will result in approximately 290,000 Medicare Advantage members transitioning to Molina. The consideration for the transactions is estimated to be approximately $117 million. Molina's acquisition of such Medicare Advantage assets is subject to CMS approvals and actions, customary closing conditions including state and other regulatory approvals, as well as the resolution, of the pending litigation brought by the US Department of Justice challenging Aetna's proposed acquisition of Humana. Register for free on Stock-Callers.com and download the PDF research report on MOH at: http://stock-callers.com/registration/?symbol=MOH
DaVita HealthCare Partners
Denver, Colorado headquartered DaVita HealthCare Partners Inc.'s shares recorded a trading volume of 3.93 million shares at the end of yesterday's session, which was higher than their three months average volume of 943,260 shares. The stock closed the day at $72.31, dropping 4.05%. The Company's shares have advanced 3.73% on an YTD basis and are trading below their 200-day moving average by 0.54%. Additionally, shares of DaVita HealthCare Partners, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have an RSI at 29.09.
On August 8th, 2016, DaVita HealthCare Partners reported that net income attributable to the company for the three months ended June 30th, 2016 was $53 million, or $0.26 per share, as compared to net income attributable to the company for the three months ended June 30th, 2015 of $170 million, or $0.78 per share. The company reported that total U.S. dialysis treatments for Q2 2016 were 6,745,610, or 86,482 treatments per day, representing a per day increase of 4.4% over Q2 2015. Get free access to your research report on DVA at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: email@example.com Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1B
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA